Lenacapavir-impurities | Pharmaffiliates

Lenacapavir and its Impurities

Lenacapavir, sold under the brand name Sunlenca, is an antiretroviral medication used to treat HIV/AIDS. Reference standards of Lenacapavir API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 3 results for Lenacapavir Impurities
PA 12 2090000

Lenacapavir - API Standards

Lenacapavir


  • Catalogue No.:PA 12 2090000

  • CAS :

    2189684-44-2

  • Molecular Formula : C39H32ClF10N7O5S2

  • Molecular Weight : 968.28

PA 12 2091000

2-((3bR,4aS)-5,5-Difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetic Acid

2-((3bR,4aS)-5,5-Difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetic Acid


  • Catalogue No.:PA 12 2091000

  • CAS :

    2189680-65-5

  • Molecular Formula : C10H7F5N2O2

  • Molecular Weight : 282.17

PA 12 2091001

N-((S)-1-(3-(4-Chloro-3-(N-(methylsulfonyl)methylsulfonamido)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide

N-((S)-1-(3-(4-Chloro-3-(N-(methylsulfonyl)methylsulfonamido)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide


  • Catalogue No.:PA 12 2091001

  • CAS :

    2189684-58-8

  • Molecular Formula : C40H34ClF10N7O7S3

  • Molecular Weight : 1046.37